Modifications of longitudinally extensive transverse myelitis and brainstem lesions in the course of neuromyelitis optica (NMO): A population-based, descriptive study

BMC Neurology

Volumn 13, Issue , 2013, Pages

  Asgari, Nasrin ^a,d   Skejoe, Hanne Pernille Bro ^b   Lillevang, Soeren Thue ^c   Steenstrup, Troels ^d   Stenager, Egon ^a,d   Kyvik, Kirsten Ohm ^d  

^a Sonderborg Hospital   (Denmark)

^b Aleris Hamlet Hospital   (Denmark)

^c ODENSE UNIVERSITY HOSPITAL   (Denmark)

^d UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

Author keywords

Anti aquaporin 4 antibody; Area postrema; Brainstem lesions; Longitudinally extensive transverse myelitis; Magnetic resonance imaging; Neuromyelitis optica

Indexed keywords

AQUAPORIN 4 ANTIBODY;

ADOLESCENT; ADULT; AREA POSTREMA; ARTICLE; BRAIN STEM INJURY; CLINICAL ARTICLE; DESCRIPTIVE RESEARCH; DIENCEPHALON; DISEASE COURSE; EXPANDED DISABILITY STATUS SCALE; FEMALE; FOLLOW UP; HUMAN; LONGITUDINALLY EXTENSIVE TRANSVERSE MYELITIS; MALE; MEDULLA OBLONGATA; MESENCEPHALON; MYELITIS; MYELOOPTIC NEUROPATHY; NUCLEAR MAGNETIC RESONANCE IMAGING; PONS; POPULATION RESEARCH; REMISSION; RETROSPECTIVE STUDY; SERODIAGNOSIS; SPINAL CORD ATROPHY;

ANTIBODIES; AQUAPORIN 4; BRAIN INJURIES; BRAIN STEM; COMMUNITY HEALTH PLANNING; FEMALE; HUMANS; LONGITUDINAL STUDIES; MAGNETIC RESONANCE IMAGING; MALE; MYELITIS, TRANSVERSE; NEUROMYELITIS OPTICA; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84875867182     PISSN: None     EISSN: 14712377     Source Type: Journal    
DOI: 10.1186/1471-2377-13-33     Document Type: Article

References (30)

1. Cloys D, Netsky M. Neuromyelitis optica. Handbook of clinical neurology 1970, 426-436. North-Holland: Amsterdam, Viken PJ BG, 9.
2. Asgari N, Lillevang ST, Skejoe HP, Falah M, Stenager E, Kyvik KO. A population-based study of neuromyelitis optica in Caucasians. Neurology 2011, 76:1589-1595. 10.1212/WNL.0b013e3182190f74, 3269768, 21536639.
3. Pittock SJ, Lennon VA, Krecke K, Wingerchuk DM, Lucchinetti CF, Weinshenker BG. Brain abnormalities in neuromyelitis optica. Arch Neurol 2006, 63:390-396. 10.1001/archneur.63.3.390, 16533966.
4. Wingerchuk DM, Lennon VA, Pittock SJ, Lucchinetti CF, Weinshenker BG. Revised diagnostic criteria for neuromyelitis optica. Neurology 2006, 66:1485-1489. 10.1212/01.wnl.0000216139.44259.74, 16717206.
5. Collongues N, Marignier R, Zephir H, Papeix C, Blanc F, Ritleng C. Neuromyelitis optica in France: a multicenter study of 125 patients. Neurology 2010, 74:736-742. 10.1212/WNL.0b013e3181d31e35, 20194912.
6. Cabrera-Gomez JA, Kister I. Conventional brain MRI in neuromyelitis optica. Eur J Neurol 2012, 19:812-819. 10.1111/j.1468-1331.2011.03565.x, 22040258.
7. Jarius S, Ruprecht K, Wildemann B, Kuempfel T, Ringelstein M, Geis C. Contrasting disease patterns in seropositive and seronegative neuromyelitis optica: A multicentre study of 175 patients. J Neuroinflammation 2012, 9:14. 10.1186/1742-2094-9-14, 3283476, 22260418.
8. Kim W, Kim SH, Huh SY, Kim HJ. Brain abnormalities in neuromyelitis optica spectrum disorder. Mult Scler Int 2012, 201(2):735486.
9. Nakashima I, Fujihara K, Miyazawa I, Misu T, Narikawa K, Nakamura M. Clinical and MRI features of Japanese patients with multiple sclerosis positive for NMO-IgG. J Neurol Neurosurg Psychiatry 2006, 77:1073-1075. 10.1136/jnnp.2005.080390, 2077753, 16505005.
10. Pittock SJ, Weinshenker BG, Lucchinetti CF, Wingerchuk DM, Corboy JR, Lennon VA. Neuromyelitis optica brain lesions localized at sites of high aquaporin 4 expression. Arch Neurol 2006, 63:964-968. 10.1001/archneur.63.7.964, 16831965.
11. Poppe AY, Lapierre Y, Melancon D, Lowden D, Wardell L, Fullerton LM. Neuromyelitis optica with hypothalamic involvement. Mult Scler 2005, 11:617-621. 10.1191/1352458505ms1200cr, 16193902.
12. Magana SM, Matiello M, Pittock SJ, McKeon A, Lennon VA, Rabinstein AA. Posterior reversible encephalopathy syndrome in neuromyelitis optica spectrum disorders. Neurology 2009, 72:712-717. 10.1212/01.wnl.0000343001.36493.ae, 19237699.
13. Apiwattanakul M, Popescu BF, Matiello M, Weinshenker BG, Lucchinetti CF, Lennon VA. Intractable vomiting as the initial presentation of neuromyelitis optica. Ann Neurol 2010, 68:757-761. 10.1002/ana.22121, 21031587.
14. Misu T, Fujihara K, Nakashima I, Sato S, Itoyama Y. Intractable hiccup and nausea with periaqueductal lesions in neuromyelitis optica. Neurology 2005, 65:1479-1482. 10.1212/01.wnl.0000183151.19351.82, 16275842.
15. Lucchinetti CF, Mandler RN, McGavern D, Bruck W, Gleich G, Ransohoff RM. A role for humoral mechanisms in the pathogenesis of Devic's neuromyelitis optica. Brain 2002, 125:1450-1461. 10.1093/brain/awf151, 12076996.
16. Asgari N, Khorooshi R, Lillevang ST, Owens T. Complement-dependent pathogenicity of brain-specific antibodies in cerebrospinal fluid. J Neuroimmunol 2013, 254:76-82. 10.1016/j.jneuroim.2012.09.010, 23031833.
17. Amiry-Moghaddam M, Ottersen OP. The molecular basis of water transport in the brain. Nat Rev Neurosci 2003, 4:991-1001. 10.1038/nrn1252, 14682361.
18. Popescu BF, Lennon VA, Parisi JE, Howe CL, Weigand SD, Cabrera-Gomez JA. Neuromyelitis optica unique area postrema lesions: nausea, vomiting, and pathogenic implications. Neurology 2011, 76:1229-1237. 10.1212/WNL.0b013e318214332c, 3068006, 21368286.
19. Kurtzke JF. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 1983, 33:1444-1452. 10.1212/WNL.33.11.1444, 6685237.
20. Cassinotto C, Deramond H, Olindo S, Aveillan M, Smadja D, Cabre P. MRI of the spinal cord in neuromyelitis optica and recurrent longitudinal extensive myelitis. J Neuroradiol 2009, 36:199-205. 10.1016/j.neurad.2008.12.008, 19223076.
21. Asgari N, Nielsen C, Stenager E, Kyvik KO, Lillevang ST. HLA, PTPN22 and PD-1 associations as markers of autoimmunity in neuromyelitis optica. Mult Scler 2012, 18:23-30.
22. Jarius S, Frederikson J, Waters P, Paul F, Akman-Demir G, Marignier R. Frequency and prognostic impact of antibodies to aquaporin-4 in patients with optic neuritis. J Neurol Sci 2010, 298:158-162. 10.1016/j.jns.2010.07.011, 20850793.
23. Lu Z, Zhang B, Qiu W, Kang Z, Shen L, Long Y. Comparative brain stem lesions on MRI of acute disseminated encephalomyelitis, neuromyelitis optica, and multiple sclerosis. PLoS One 2011, 6:e22766. 10.1371/journal.pone.0022766, 3154259, 21853047.
24. Jarius S, Franciotta D, Paul F, Ruprecht K, Bergamaschi R, Rommer PS. Cerebrospinal fluid antibodies to aquaporin-4 in neuromyelitis optica and related disorders: frequency, origin, and diagnostic relevance. J Neuroinflammation 2010, 7:52. 10.1186/1742-2094-7-52, 2945323, 20825655.
25. Wingerchuk DM, Lennon VA, Lucchinetti CF, Pittock SJ, Weinshenker BG. The spectrum of neuromyelitis optica. Lancet Neurol 2007, 6:805-815. 10.1016/S1474-4422(07)70216-8, 17706564.
26. Asgari N, Owens T, Frokiaer J, Stenager E, Lillevang ST, Kyvik KO. Neuromyelitis optica (NMO)-an autoimmune disease of the central nervous system (CNS). Acta Neurol Scand 2011, 123:369-384. 10.1111/j.1600-0404.2010.01416.x, 20880299.
27. Takahashi T, Miyazawa I, Misu T, Takano R, Nakashima I, Fujihara K. Intractable hiccup and nausea in neuromyelitis optica with anti-aquaporin-4 antibody: a herald of acute exacerbations. J Neurol Neurosurg Psychiatry 2008, 79:1075-1078. 10.1136/jnnp.2008.145391, 18420727.
28. Weinshenker BG, Wingerchuk DM, Vukusic S, Linbo L, Pittock SJ, Lucchinetti CF. Neuromyelitis optica IgG predicts relapse after longitudinally extensive transverse myelitis. Ann Neurol 2006, 59:566-569. 10.1002/ana.20770, 16453327.
29. Krampla W, Aboul-Enein F, Jecel J, Lang W, Fertl E, Hruby W. Spinal cord lesions in patients with neuromyelitis optica: a retrospective long-term MRI follow-up study. Eur Radiol 2009, 19:2535-2543. 10.1007/s00330-009-1425-3, 19415287.
30. Losseff NA, Kingsley DP, McDonald WI, Miller DH, Thompson AJ. Clinical and magnetic resonance imaging predictors of disability in primary and secondary progressive multiple sclerosis. Mult Scler 1996, 1:218-222.